PRKAA1 and obesity due to melanocortin 4 receptor deficiency: Activation of AMPK by antidiabetic drugs, such as metformin, can alleviate hyperglycemia in obesity and type 2 diabetes mellitus (T2DM) by suppressing liver glucose production (8, 9, 10).